Foundation News

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today

NEW YORK, NY – Dietary supplementation of pomegranate extract decreased disease severity and lowered inflammation in mice with colitis, according to a new study published in Molecular Nutrition and Food Research and

Prometheus Laboratories recently announced the launch of PredictrPK IFX, which uses a machine learning algorithm to combine patient weight, current dose and interval, measured serum IFX, measured antibodies-to-infliximab and albumin levels to predict optimal, individualized infliximab dosing.

CEO Michael Osso recently spoke with Fast Company about how the We Can’t Wait app is connecting users to over 45,000 public restrooms across the country.

NEW YORK, NY — The Crohn’s & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, today launched the We Can’t Wait app, which provides an interactive map that allows users to find a restroom near them

ORANGE COUNTY, CA – 11 Health & Technologies Inc., a medical technology company with a proven technology to reduce complications in ostomy patients, announced today that it has received funding from the Crohn’s & Colitis Foundation’s

New York, NY – The Crohn’s & Colitis Foundation today announced a breakthrough in the study of intestinal fibrosis in inflammatory bowel disease (IBD) patients, published in IBD Journal.

NEW YORK, NY – Crohn’s disease and ulcerative colitis, also known as inflammatory bowel disease (IBD), affect millions of Americans and can significantly impair patient quality of life.

New York, NY -- The Crohn’s & Colitis Foundation (the Foundation) announced today that it received a $3 million donation from Jonathan D. Rose, MD, PhD, to support two major Foundation research programs: IBD-SIRQC, a national, prospective surgical cohort, and the Jonathan D.

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o

NEW YORK, NY – The Crohn’s & Colitis Foundation (the Foundation) has named Dr. David T.

New York, NY – For Crohn’s disease patients with mild-to-moderate symptoms, a Mediterranean style diet and the Specific Carbohydrate Diet™ appear to improve symptoms and quality of life, according to a new study published in